These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3158477)

  • 1. Oral contraceptives and pituitary response to GnRH: comparative study of progestin-related effects.
    Römmler A; Baumgarten S; Moltz L; Schwartz U; Hammerstein J
    Contraception; 1985 Mar; 31(3):295-303. PubMed ID: 3158477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-estrogenic effects of contraceptive progestins on the dynamics of gonadotropin release.
    Römmler A; Baumgarten S; Schwartz U; Hammerstein J
    Contraception; 1982 Jun; 25(6):619-27. PubMed ID: 6214371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
    Kuhl H; Weber W; Mehlis W; Sandow J; Taubert HD
    Contraception; 1984 Nov; 30(5):467-82. PubMed ID: 6083846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LH-RH+.
    Dericks-Tan JS; Krög W; Aktories K; Taubert HD
    Contraception; 1976 Aug; 14(2):171-81. PubMed ID: 780050
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA; Brenner PF; Kletzky OA; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of oral contraceptives on integrated secretion of gonadotropins.
    Dericks-Tan JS; Gudacker V; Taubert HD
    Contraception; 1992 Oct; 46(4):369-77. PubMed ID: 1486775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
    Porcile A; Gallardo E
    Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD
    Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA; Elkind-Hirsch KE; Malinak R
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary repetitive stimulation with GnRH/TRH in women treated with three different oral steroid contraceptives.
    Pérez-López FR
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):163-7. PubMed ID: 2107650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low estrogen oral contraceptives and the hypothalamo-pituitary axis.
    De Leo V; Lanzetta D; Vanni AL; D'Antona D; Severi FM
    Contraception; 1991 Aug; 44(2):155-61. PubMed ID: 1832628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive.
    Ling WY; Johnston DW; Lea RH; Bent AE; Scott JZ; Toews MR
    Contraception; 1985 Oct; 32(4):367-75. PubMed ID: 3935373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ; Kletzky OA; Brenner PF; Mishell DR
    Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.